MyAverix Finance
US · Healthcare
Crispr Therapeutics AG (CRSP)
Biotechnology
Crispr Therapeutics AG (CRSP) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CRSP
Crispr Therapeutics AG (CRSP) — FAQ
What is CRSP's P/E ratio?
The price-to-earnings (P/E) ratio for Crispr Therapeutics AG (CRSP) is 18.00 (data as of 2026-03-23).
Does Crispr Therapeutics AG pay a dividend?
Dividend yield is not available in the current snapshot for Crispr Therapeutics AG (CRSP). Check the MyAverix Finance app for the latest dividend data.
What sector is Crispr Therapeutics AG in?
Crispr Therapeutics AG (CRSP) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CRSP listed on?
CRSP is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.